To investigate the immunotherapeutic efficacy in the selected syngeneic tumor mice, we constructed and purified αPD-L1scFv-hFc antibody based on Atezolizumab, an antibody targeting PD-L1, which was detected by silver staining (Fig. 7A). The gene discussed is CD274; the disease is neoplasm.